IPD 1.37% 7.2¢ impedimed limited

Catalysts for the inevitable price POP, page-36

  1. 157 Posts.
    lightbulb Created with Sketch. 25
    Based on my understanding BIS is approved for guidance for Lymphoma, which strongly links to, but does not mandate it for use for other cancers. I.e if a patient has cancer but no signs or symptoms of Lymphoma, then insurers will not pick up the tab.
 
watchlist Created with Sketch. Add IPD (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
-0.001(1.37%)
Mkt cap ! $145.6M
Open High Low Value Volume
7.3¢ 7.3¢ 6.8¢ $99.51K 1.414M

Buyers (Bids)

No. Vol. Price($)
1 70000 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 759489 4
View Market Depth
Last trade - 16.10pm 18/06/2024 (20 minute delay) ?
IPD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.